当前位置: 首页 > 期刊 > 《中国医学创新》 > 2021年第11期
编号:186202
玉屏风颗粒联合锌剂对支气管哮喘患儿血清炎性因子及免疫球蛋白水平的影响
http://www.100md.com 2021年6月2日 中国医学创新 2021年第11期
     钟海燕

    【摘要】 目的:探讨玉屏风颗粒联合锌剂治疗支气管哮喘的临床效果和对血清炎性因子的影响。方法:选取2018年9月-2020年9月于本院就诊的86例支气管哮喘患儿,按随机数字表法分为对照组和观察组,各43例。两组均接受常规治疗,在此基础上,对照组予以葡萄糖酸锌治疗,观察组采用玉屏风颗粒联合葡萄糖酸锌治疗。比较两组血清炎性因子水平、免疫球蛋白水平和不良反应发生情况。结果:治疗后,观察组白介素-17(IL-17)、C反应蛋白(CRP)和肿瘤坏死因子-α(TNF-α)水平均低于对照组,差异均有统计学意义(P0.05)。结论:玉屏风颗粒联合锌剂可改善支气管哮喘患儿机体免疫功能,降低气道炎症反应,不增加不良反应发生率。

    【关键词】 支气管哮喘 玉屏风颗粒 葡萄糖酸锌 炎性因子 免疫球蛋白

    [Abstract] Objective: To investigate the clinical effect of Yupingfeng Granules combined with zinc in the treatment of bronchial asthma and its influence on serum inflammation. Method: A total of 86 children with bronchial asthma who were treated in our hospital from September 2018 to September 2020 were selected, they were divided into control group and observation group, according to the random number table, with 43 cases in each group. Both groups received conventional treatment, on this basis, the control group was treated with Zinc Gluconate ......

您现在查看是摘要页,全文长 9686 字符